Shionogi outlines plans for Europe
This article was originally published in Scrip
Executive Summary
As part of its ambitions to build a global presence, the Japanese firm Shionogi now wants to make its mark in Europe and has opened offices in London. Takashi Takenoshita, Shionogi's head of the new European operations, joined Scrip in the podcast studio to discuss where the firm plans to go and how it hopes to succeed.
You may also be interested in...
Lack Of Industry Involvement In EU HTA Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
German HTA Queries Polivy Benefits Amid Lack Of Evidence
Roche’s lymphoma drug Polivy could face pricing challenges in Germany as it undergoes a full benefit assessment.
Germany Confirms No Reimbursement Status For ‘Lifestyle’ Drug Wegovy
In Germany Novo Nordisk’s obesity drug Wegovy will remain excluded from reimbursement for obesity, unlike Rhythm’s Imcivree.